Symbol | Exchange | Currency |
|---|
Investing.com – U.S. stocks were mixed after the close on Monday, as gains in the Consumer Goods, Consumer Services and Healthcare sectors led shares higher while losses in the Oil...
Investing.com – U.S. stocks were higher after the close on Thursday, as gains in the Basic Materials, Oil & Gas and Consumer Goods sectors led shares higher. At the close in NYSE,...
Investing.com – U.S. stocks were higher after the close on Friday, as gains in the Technology, Basic Materials and Healthcare sectors led shares higher. At the close in NYSE, the...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Strong Sell | Strong Sell | Sell | Buy |
| Technical Indicators | Sell | Strong Sell | Sell | Strong Sell | Strong Buy |
| Summary | Sell | Strong Sell | Strong Sell | Strong Sell | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 2,660.30 | 2,668.00 | 2,596.00 | +91.9 | +3.58% | 2.08M | NASDAQ | |||
| 369.79 | 375.33 | 357.19 | +18.60 | +5.30% | 33.69M | NASDAQ | |||
| 9.98 | 9.98 | 9.96 | +0.010 | +0.10% | 53.52K | NASDAQ | |||
| 75.94 | 76.04 | 74.89 | +0.41 | +0.54% | 12.35M | NASDAQ | |||
| 3.20 | 3.39 | 3.13 | -0.040 | -1.23% | 14.27K | NASDAQ | |||
| 4.64 | 4.857 | 4.415 | +0.040 | +0.87% | 49.72K | NASDAQ | |||
| 124.62 | 130.73 | 116.16 | -10.06 | -7.47% | 8.68M | NASDAQ | |||
| 36.81 | 36.87 | 36.27 | 0.00 | 0.00% | 0.00 | NASDAQ | |||
| 7.00 | 7.10 | 6.39 | 0.00 | 0.00% | 13.60K | NASDAQ | |||
| 42.52 | 43.38 | 42.48 | -0.13 | -0.30% | 291.17K | NYSE | |||
| 0.7299 | 0.00 | 0.00 | -0.0801 | -9.89% | 1.73M | NASDAQ | |||
| 195.58 | 197.00 | 192.50 | -0.36 | -0.18% | 19.57M | NASDAQ | |||
| 46.51 | 47.20 | 46.12 | +0.60 | +1.31% | 5.03M | NYSE | |||
| 57.01 | 57.33 | 56.45 | +0.54 | +0.96% | 12.14M | NYSE | |||
| 55.34 | 56.28 | 54.73 | -0.90 | -1.60% | 10.62M | NYSE |
Interpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States. The company offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion genomic test that helps physicians better assess risk of pancreaticobiliary cancers using its PathFinderTG platform; and ThyGeNEXT, an oncogenic mutation panel to identify malignant thyroid nodules. It also provides ThyraMIR assesses thyroid nodules for risk of malignancy utilizing a proprietary microRNA gene-expression assay; and RespriDx, a genomic test that helps physicians to differentiate metastatic or recurrent lung cancer. The company also provides pharmacogenomics testing, genotyping, biorepository, and other customized services to the pharmaceutical and biotech industries. It primarily serves physicians, hospitals, and clinics. The company was formerly known as Interpace Diagnostics Group, Inc. and changed its name to Interpace Biosciences, Inc. in November 2019. Interpace Biosciences, Inc. was incorporated in 1986 and is headquartered in Parsippany, New Jersey.
